152 related articles for article (PubMed ID: 16972687)
21. Pharmacologic management of Paget's disease.
Stumpf JL
Clin Pharm; 1989 Jul; 8(7):485-95. PubMed ID: 2666012
[TBL] [Abstract][Full Text] [Related]
22. Paget's disease of bone: presentation, extent and response to bisphosphonates.
Wang LM; Au-Yeong ML; McKenna MJ
Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonate use in the treatment of Paget's disease of the bone: analysis of claims in a large database.
Dolgitser M; Stern L; Katz LM; Doyle JJ; Omar M; Seton M; Kahler KH
Manag Care Interface; 2007 Feb; 20(2):33-40. PubMed ID: 17405580
[TBL] [Abstract][Full Text] [Related]
24. Paget's disease of bone--current thinking and management.
Hughes S; Peel-White AL; Peterson CK
J Manipulative Physiol Ther; 1992 May; 15(4):242-9. PubMed ID: 1321871
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates in the management of Paget's disease.
Ralston SH
Bone; 2020 Sep; 138():115465. PubMed ID: 32512166
[TBL] [Abstract][Full Text] [Related]
26. Drug treatment strategies for paget's disease: relieving pain and preventing progression.
Merlotti D; Rendina D; Cavati G; Abate V; Falchetti A; Mingiano C; Nuti R; Gennari L
Expert Opin Pharmacother; 2023 Apr; 24(6):715-727. PubMed ID: 36961938
[TBL] [Abstract][Full Text] [Related]
27. Paget's disease of bone and its complications due to delay in diagnosis.
Almeida LP; Scrignoli JA; Santos SC; Passos LF; Ribeiro SL
Acta Reumatol Port; 2011; 36(3):288-91. PubMed ID: 22116190
[TBL] [Abstract][Full Text] [Related]
28. Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy.
Rendina D; Gennari L; De Filippo G; Merlotti D; de Campora E; Fazioli F; Scarano G; Nuti R; Strazzullo P; Mossetti G
J Bone Miner Res; 2006 Dec; 21(12):1828-35. PubMed ID: 17002563
[TBL] [Abstract][Full Text] [Related]
29. Osteosarcoma in Paget's disease of bone.
Hansen MF; Seton M; Merchant A
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P58-63. PubMed ID: 17229010
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and pharmacologic treatment of Paget's disease.
Hamdy RC
Endocrinol Metab Clin North Am; 1995 Jun; 24(2):421-36. PubMed ID: 7656897
[TBL] [Abstract][Full Text] [Related]
31. [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].
Ringe JD; Reginster JY; Gennari C; Hosking DJ; Meunier PJ
Z Rheumatol; 1996; 55(4):256-9. PubMed ID: 8967186
[TBL] [Abstract][Full Text] [Related]
32. Antibody Response to Paramyxoviruses in Paget's Disease of Bone.
Visconti MR; Usategui-Martín R; Ralston SH
Calcif Tissue Int; 2017 Aug; 101(2):141-147. PubMed ID: 28361207
[TBL] [Abstract][Full Text] [Related]
33. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Nuti R; Turchetti V; Righi G; Vattimo A
Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
[TBL] [Abstract][Full Text] [Related]
34. [Disorder of bone quality in Paget's disease].
Tsurukami H
Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714
[TBL] [Abstract][Full Text] [Related]
35. Paget's Disease of Bone: Progress Towards Remission and Prevention.
Healy GM; Woods C; Heffernan E; McKenna MJ
Ir Med J; 2015; 108(10):316-7. PubMed ID: 26817293
[TBL] [Abstract][Full Text] [Related]
36. Paget's disease of bone: histologic analysis of 754 patients.
Seitz S; Priemel M; Zustin J; Beil FT; Semler J; Minne H; Schinke T; Amling M
J Bone Miner Res; 2009 Jan; 24(1):62-9. PubMed ID: 18767930
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological therapy of Paget's and other metabolic bone diseases.
Hosking D
Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
[TBL] [Abstract][Full Text] [Related]
38. Increased circulating Dickkopf-1 in Paget's disease of bone.
Marshall MJ; Evans SF; Sharp CA; Powell DE; McCarthy HS; Davie MW
Clin Biochem; 2009 Jul; 42(10-11):965-9. PubMed ID: 19389391
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.
Lucas GJ; Mehta SG; Hocking LJ; Stewart TL; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Watts GD; Ralston SH; Kimonis VE
Bone; 2006 Feb; 38(2):280-5. PubMed ID: 16199218
[TBL] [Abstract][Full Text] [Related]
40. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
